Neutron Therapeutics' Accelerator Receives Final Acceptance at University of Birmingham's High Flux Accelerator-Driven Neutron Facility
Neutron Therapeutics , a leading developer of accelerator-based neutron systems for targeted radiation therapy of solid tumors, today announced that its compact accelerator has received final acceptance for use at the University of Birmingham's High Flux Accelerator-Driven Neutron Facility.
- Neutron Therapeutics , a leading developer of accelerator-based neutron systems for targeted radiation therapy of solid tumors, today announced that its compact accelerator has received final acceptance for use at the University of Birmingham's High Flux Accelerator-Driven Neutron Facility.
- This first-of-its-kind facility will enable research into the effects of neutrons in a variety of fields, including nuclear energy, nuclear science and boron neutron capture therapy (BNCT).
- This facility is the United Kingdom’s first high-flux neutron test facility.
- “The compact accelerator at the University of Birmingham’s neutron facility provides an excellent environment for researchers conducting pre-clinical research in boron neutron capture therapy,” said Professor Stuart Green, director of medical physics at University Hospital Birmingham.